In focus
Latest feed
Pfizer's Recent Rally: A Fleeting Illusion or Sustainable Recovery?
Huntsville's Bold Bet: Unpacking the Multi-Billion-Dollar Eli Lilly Investment
AstraZeneca's Stellar Q4 Performance: Cancer Drugs Propel Growth and Investor Confidence
Turning the Page: Twist Bioscience Narrows Losses, Eyes 2026 Profitability with Renewed Vigor
